Stock Report

Download full stock data and analysis for free Last Updated: 27-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Vivanza Bioscience Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 530057

₹1.82

up-down-arrow ₹0.09 (5.20%)

As on 26-Aug-2026IST

Market cap

info icon

₹7 Cr

Revenue (TTM)

info icon

₹116 Cr

P/E Ratio

info icon

16

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 46.00 3.93 734.98 67.62 65.27
EBIT 65.02 -157.43 182.85 -24.58 18.70
Net Profit 132.52 65.91 153.64 -23.43 -4.15
EPS 132.54 69.12 153.21 -23.60 -4.33
Book Value -- -- 9.95 2.13 6.65
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -2.200.520.420.62-4.97
Net Margin info -6.94-0.090.390.34-9.01
Return on equity info -0.016.4310.199.48-15.67
Return on Capital info 4.167.32--6.09-2.74
Return on Assets info -0.161.362.372.05-3.75
Debt to Equity (x) info ----0.202.342.18

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
6.09
-2.74
10.18
10.83
Peer Median
--
30.60
3.84
5.02
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

10.19

Higher than Peers by 8.66

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
10.19
9.48
-15.67
12.54
15.78
Peer Median
1.53
29.06
5.08
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

2.37

Higher than Peers by 1.59

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
2.37
2.05
-3.75
2.61
3.15
Peer Median
0.78
14.98
2.19
1.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

0.42

Higher than Peers by 9.24

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
0.42
0.62
-4.97
3.81
3.74
Peer Median
-8.83
--
2.93
3.78
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

0.39

Lower than Peers by 1.73

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
0.39
0.34
-9.01
1.96
3.27
Peer Median
2.12
8.35
1.96
3.27
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
0.00
0.36
-8.89
2.01
3.37
Peer Median
--
--
0.00
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

734.98

Higher than Peers by 740.65

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
734.98
1,461.44
-73.33
56.31
71.22
Peer Median
-5.67
--
50.75
56.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

182.85

Higher than Peers by 242.79

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
182.85
293.80
-134.83
59.02
1,175.00
Peer Median
-59.94
--
75.04
59.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

153.64

Higher than Peers by 124.57

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
153.64
158.51
-223.17
-8.52
79.67
Peer Median
29.07
--
39.96
-8.68
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

153.21

Higher than Peers by 166.06

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
153.21
158.52
-223.17
-8.56
79.59
Peer Median
-12.85
--
-21.00
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
9.95
-14.53
13.38
17.13
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.20

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
0.20
2.34
2.18
1.11
1.95
Peer Median
--
0.34
--
0.63
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
2.14
1.34
0.54
1.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.13

Lower than Peers by 12.94

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
1.13
1.13
1.35
1.29
1.15
Peer Median
14.07
2.15
2.47
2.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.92

Lower than Peers by 12.20

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
0.92
0.92
1.11
1.13
1.01
Peer Median
13.12
--
1.68
10.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

3.08

Lower than Peers by 4.54

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
3.08
2.92
-0.86
2.66
2.68
Peer Median
7.62
4.70
2.66
2.65
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.65

Lower than Peers by 25.51

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
10.65
10.68
108.57
41.46
70.08
Peer Median
36.16
--
15.37
42.99
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

6.03

Higher than Peers by 5.85

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
6.03
6.02
0.41
1.33
0.94
Peer Median
0.19
--
1.51
1.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
32.19
481.83
157.48
208.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
9.15
104.96
29.38
50.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
15.65
290.39
125.07
166.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
25.69
296.40
61.79
92.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

16.04

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
16.04
17.85
--
49.63
125.69
Peer Median
--
16.08
65.30
159.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.62

Higher than Peers by 1.32

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
1.62
1.62
2.01
5.86
18.38
Peer Median
0.30
1.91
2.35
3.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

17.89

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
17.89
20.23
-56.16
28.56
72.57
Peer Median
--
14.47
53.35
29.43
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

7

Lower than Peers by 25

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Vivanza Bioscience
7
7
8
27
75
Peer Median
32
125
30
20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...